A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Single and Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-490 Injection Administered Intravenously in Healthy Volunteers.

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Single and Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-490 Injection Administered Intravenously in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Feb 2012

At a glance

  • Drugs Plazomicin (Primary)
  • Indications Bacterial infections; Pyelonephritis; Respiratory tract infections; Urinary tract infections
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Achaogen
  • Most Recent Events

    • 12 Sep 2011 Results published in Antimicrobial Agents and Chemotherapy.
    • 09 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 09 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top